A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...

At least three new startups have already been launched out of the fund: U.K.-based Forth Therapeutics, French biotech ...

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...

A young man treated with Elevidys died of acute liver failure. The case may give doctors pause before prescribing the ...